Ram Mukunda - 03 Feb 2026 Form 4 Insider Report for IGC Pharma, Inc. (IGC)

Role
CEO, Director
Signature
/s/ Ram Mukunda
Issuer symbol
IGC
Transactions as of
03 Feb 2026
Net transactions value
$0
Form type
4
Filing time
04 Feb 2026, 17:31:07 UTC
Previous filing
20 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mukunda Ram CEO, Director 10224 FALLS ROAD, POTOMAC /s/ Ram Mukunda 04 Feb 2026 0001047575

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGC Common Stock Options Exercise $0 +50,000 +6.2% $0.000000 860,752 03 Feb 2026 BY SPOUSE F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IGC Restricted Stock Units Award $0 +16,667 $0.000000 16,667 03 Feb 2026 Common Stock 16,667 BY SPOUSE F2, F4
transaction IGC Restricted Stock Units Award $0 +66,666 $0.000000 66,666 03 Feb 2026 Common Stock 66,666 BY SPOUSE F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 3, 2026, the Reporting Person's spouse were granted RSUs subject to immediate vesting.
F2 On February 3, 2026, the Reporting Person's spouse were granted RSUs subject to vesting on March 31, 2026.
F3 On February 3, 2026, the Reporting Person's spouse were granted RSUs subject to vesting equally over two years starting on March 31, 2026.
F4 Each restricted stock unit represents a right to receive one share of IGC common stock.